Navigation Links
Scientists take cancer research back to the basic molecular level
Date:9/15/2008

PHILADELPHIA Scientists and clinicians from around the world will gather in Philadelphia, Pennsylvania, next week at the American Association for Cancer Research's third International Conference on Molecular Diagnostics in Therapeutic Development.

The conference is subtitled, "Fulfilling the Promise of Personalized Medicine," which reflects the potential of molecular diagnostics to provide new strategies for tailoring therapies to fit the needs of each cancer patient's unique biology.

Sessions will include discussions on the use of biomarkers in clinical practice and new drug development, advanced imaging technologies for diagnosis, and the application of proteomics in personalized medicine.

Novel findings to be reported at the conference include:

  • A new gene expression analysis that shows important differences in brain cancer.
  • A groundbreaking method of measuring changes in DNA .
  • A new biomarker that could more accurately determine the prognosis of patients with head and neck carcinoma.
  • A more complete and accurate test for blood disorders.

"As genetic, proteomic, imaging and other new technologies have become more sophisticated and our knowledge of tumor biology and signaling pathways advances, so too does our ability to molecularly characterize individual tumors and identify germ line and somatic determinants of patient prognosis and response," said conference chairperson Gordon B. Mills, M.D., Ph.D., chairman of the Department of Molecular Therapeutics at the University of Texas M. D. Anderson Cancer Center.

"This new era of personalized medicine has brought with it great opportunities to enhance cancer drug development and improve patient care," said Mills. "However, in order to harness this potential and maximize these opportunities, it is essential that there be an ongoing exchange of new ideas and information."

In addition to the symposia and poster sessions, the conference will include two keynote lectures. The first will be from David Sidransky, M.D., director of head and neck cancer research at the Johns Hopkins Hospital, who will deliver, "Personalized Cancer Medicine in the Next Decade." The second will be from Joe W. Gray, Ph.D., director of the Division of Life Sciences at the Lawrence Berkley National Laboratory, who will speak on, "Models of Molecular Diversity to Facilitate Marker Guided Therapy."


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... on the world stage this week. A group of researchers and leaders from ... the Progress of Regenerative Medicine and Its Cultural Impact ” and receive the ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... accessories, is proud to partner with AquaShieldUSA, the country's oldest waterproof cast ... clinic and medical supply stores, the largest selection of daily, night, weatherproof and ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the open availability of a new CDISC standard, Clinical Trial Registry (CTR) ... trials. This innovative standard will make it possible to build applications that ...
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... ... 28, 2016 , ... In 2011, TIME magazine named Herr the “Leader of ... technology that marries human physiology with electromechanics. He continues that work as Director of ... of BionX , a leader in the field of prosthetic devices. , After ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  The blood testing market in China ... Information and The Freedonia Group in a recent report.  ... The healthcare research firm said that China ... stations and in improving testing at the provincial level.  ... Blood Testing Market in China , which ...
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
Breaking Medicine Technology: